Designates November 7 of each year as "Shwachman Diamond Syndrome Awareness Day" in NJ.
Impact
The resolution highlights the severity of SDS, which affects approximately 1 in 80,000 newborns and leads to significant health complications, including bone marrow dysfunction, pancreatic insufficiency, and various developmental challenges. It notes the critical need for ongoing treatment and monitoring for affected individuals, emphasizing that current treatment options only alleviate symptoms rather than provide a cure. The designation of an awareness day aims to improve public knowledge, encourage research funding, and enhance support for those impacted by the disease.
Summary
AJR119 is a Joint Resolution that designates November 7 of each year as 'Shwachman Diamond Syndrome Awareness Day' in New Jersey. The aim of this resolution is to increase awareness of Shwachman-Diamond syndrome (SDS), a rare genetic disorder affecting the bone marrow, pancreas, and skeleton. By establishing a designated day, the resolution seeks to promote understanding of the disease and its implications for individuals affected by it, as well as to foster increased research efforts into effective treatments.
Contention
While the resolution seeks to positively influence public health awareness, there may be limited discussion regarding the adequacy of existing healthcare resources to address the needs of individuals with SDS. Additionally, given the rarity of the syndrome, some stakeholders may question the allocation of resources towards awareness programs compared to more prevalent health issues. However, the resolution's supporters argue that increasing awareness can lead to earlier diagnoses and better management of the disorder, ultimately improving outcomes for those living with SDS.